Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06420973
Status:
RECRUITING
Last Update Posted:
2024-05-20
First Post:
2024-05-11
Brief Title:
RC48 Treatment for Platinum Sensitive Recurrent Ovarian Cancer With HER2 Expression
Sponsor:
Peking University Cancer Hospital Institute
Organization:
Peking University Cancer Hospital Institute
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Primary Peritoneal Carcinoma |
| Ovarian Carcinoma |
| Fallopian Tube Carcinoma |
Keywords: